|

ALN-SOD Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Regeneron Pharmaceuticals1

Indications

  • Mutation in the Superoxide Dismutase-1 (SOD1) Gene1
  • Amyotrophic Lateral Sclerosis (ALS)1
  • Multiple Sclerosis1

Other1 trial

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.